Central Surgical Association| Volume 128, ISSUE 4, P556-563, October 2000

Download started.


Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute—designated cancer center


      Background. Sentinel lymph node biopsy (SLNB) has rapidly evolved into the standard of care for clinically node-negative melanoma. Since adopting sentinel lymph node (SLN) technology in 1993, we have periodically reviewed our institution's results and made several modifications. Methods. From January 1993 to December 1998, 182 patients with clinically node-negative primary cutaneous melanoma underwent SLNB. Charts were retrospectively reviewed and assessed for the technique for the identification of the SLN, the pathologic analysis, and the use of intraoperative frozen section. Results. The accuracy of SLN identification improved from 91% to 100% with the combination of isosulfan blue dye and radiolabeled colloid over isosulfan blue dye alone. Routine versus selective lymphoscintigraphy identified 7 in-transit SLNs and increased detection of dual nodal basin drainage (15%-27%). Identification of micrometastases in the SLN increased from 14% to 24% after a modification of pathologic evaluation. The positive SLN was the only involved node in most patients (80%). Intraoperative frozen section had a sensitivity of 58% and was of benefit in only 13 of 124 patients (10%). Conclusions. Several modifications to the identification of the SLNs and the detection of metastatic melanoma have improved our outcome with SLNB. A careful, periodic review of results to identify areas for improvement at each institution is crucial to the success of SLNB for melanoma. (Surgery 2000;128:556-63.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Greenlee RT
        • Murray T
        • Bolden S
        • Wingo PA
        Cancer statistics, 2000.
        CA Cancer J Clin. 2000; 50: 7-33
        • Ross M
        The case for elective lymphadenectomy.
        Surg Oncol Clin N Am. 1992; 1: 205-222
        • Reintgen D
        • Rapaport D
        • Tanabe KK
        • Ross M
        Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
        J Fla Med Assoc. 1997; 84: 188-193
        • Morton DL
        • Wen DR
        • Wong JH
        • et al.
        Technical details of intraoperative lymphatic mapping for early stage melanoma.
        Arch Surg. 1992; 127: 392-399
        • Coit DG
        • Rogatko A
        • Brennan MF
        Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes.
        Ann Surg. 1991; 214: 627-636
        • Balch CM
        • Soong S-J
        • Shaw HM
        • et al.
        An analysis of prognostic factors in 8500 patients with cutaneous melanoma.
        in: 2nd ed. Cutaneous melanoma. Lippincott, Philadelphia1992: 165-187
        • Ariel IM
        Malignant melanoma of the trunk: a retrospective review of 1128 patients.
        Cancer. 1982; 49: 1070-1078
        • Balch CM
        • Soong SJ
        • Milton GW
        • et al.
        A comparison of prognostic factors and surgical results in 186 patients with localized melanoma treated in Alabama, USA and New South Wales, Australia.
        Ann Surg. 1982; 196: 677-684
        • Clabro A
        • Singletary SE
        • Balch CM
        Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases.
        Arch Surg. 1989; 124: 1051-1055
        • Reintgen DS
        • Cox EB
        • McCarthy Jr, KS
        • et al.
        Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
        Ann Surg. 1983; 198: 379-385
        • Milton GW
        • Shaw HM
        • McCarthy WH
        • et al.
        Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients.
        Br J Surg. 1982; 69: 108-111
        • Balch CM
        Cutaneous melanoma: prognosis and treatment results worldwide.
        Semin Surg Oncol. 1992; 8: 400-414
        • Norman J
        • Cruse CW
        • Espinosa C
        • et al.
        Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malingant melanoma.
        Am J Surg. 1991; 162: 432-437
        • Reintgen DS
        • Rapaport DP
        • Tanabe KK
        • Ross MI
        Lymphatic mapping and sentinel lymphadenectomy.
        in: 3rd ed. Cutaneous melanoma. Quality Medical Publishing, St. Louis, (Mo)1998: 224-227
        • Gershenwald JE
        • Tseng CH
        • Thompson W
        • et al.
        Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid.
        Surgery. 1998; 124: 204-210
        • Krag DN
        • Meijer SJ
        • Weiver DL
        • et al.
        Minimal access surgery for staging of malignant melanoma.
        Arch Surg. 1995; 130: 654-658
        • Albertini JJ
        • Cruse CW
        • Rapaport D
        • et al.
        Intraoperative radio lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma.
        Ann Surg. 1996; 223: 217-224
        • Reintgen D
        More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques.
        Curr Opin Oncol. 1996; 8: 152-158
        • Cochran AJ
        • Wen DR
        • Morton DL
        Occult tumor cells in lymph nodes of patients with pathological stage I malignant melanoma: an immunohistological study.
        Am J Surg Pathol. 1988; 12: 612-618
        • Gibbs JF
        • Huang PP
        • Zhang PJ
        • Kraybill WG
        • Cheney R
        Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes.
        Ann Surg Oncol. 1999; 6: 699-704